A Clinical Guide to Transcranial Magnetic Stimulation

Edited by Paul E. Holtzheimer and William McDonald

Evidenced-based approach to the practical clinical administration of rTMS
Leaders in the field discussing the applications of their research to the clinical administration of rTMS

A Clinical Guide to Transcranial Magnetic Stimulation

Edited by Paul E. Holtzheimer and William McDonald

Description

The Clinical Guide serves as a reference tool for clinicians in the administration of transcranial magnetic stimulation (TMS) for neuropsychiatric disorders. The primary intent of this Guide is to focus on the clinical applications of TMS and to offer detailed information on the safe and effective administration of TMS with consideration of the neurophysiological effects particularly in relation to safety, targeting specific cortical areas and practical issues such as the length of treatment sessions and the durability of the TMS response. The Guide focuses on the evidenced based literature and utilizes this literature to inform specific recommendations on the use of rTMS in a clinical setting. The efficacy and safety of TMS for neuropsychiatric disorders, including its use in special populations, such as the elderly, will be reviewed to facilitate clinical decision-making. The Guide will also outline setting up a TMS service including practical issues such as considerations for the qualifications of the person administering the treatment, the use of concomitant medications, what equipment is necessary to have in the treatment room and monitoring the outcomes to treatment. The Guide is intended to be a practical reference for the practicing clinician in the safe and effective administration of TMS.

A Clinical Guide to Transcranial Magnetic Stimulation

Edited by Paul E. Holtzheimer and William McDonald

1. The theoretical basis for transcranial magnetic stimulation
2. The development of transcranial magnetic stimulation technology
3. Clinical efficacy of TMS in depression
4. Safety of TMS
5. Patient selection and management
6. The practical administration of TMS in a clinical setting
7. Measuring outcomes
8. Neurophysiological measure of TMS
9. Transcranial magnetic stimulation in the treatment of psychiatric disorders
10. Development of other brain stimulation interventions
11. Limitations of TMS and future directions for clinical research

A Clinical Guide to Transcranial Magnetic Stimulation

Edited by Paul E. Holtzheimer and William McDonald

Author Information

Edited by Paul E. Holtzheimer, Associate Professor, Departments of Psychiatry and Surgery, Darmouth Medical School, and William McDonald, MD, Emory University

PEH:Woodruff Memorial Research Building, Emory University School of Medicine, Emory University

Contributors:

Mark S. George, MD, Brain Stimulation Laboratory,SC Brain Imaging Center of Excellence, MUSC
Joseph J. Taylor, Brain Stimulation Laboratory,SC Brain Imaging Center of Excellence, MUSC
Charles M. Epstein, MD, Department of Neurology, Emory University School of Medicine
Michelle L. Moyer M.D, Neuromodulation Program, Department of Psychiatry, UMDNJ SOM
Mario A. Cristancho M.D., Neuromodulation Program, Department of Psychiatry, University of Pennsylvania.
John P. O'Reardon, M.D., Neuromodulation Program, Department of Psychiatry, UMDNJ SOM
Simone Rossi, MD, PhD, Azienda Ospedaliera-Universitaria Senese, Brain Invstigation & Neuromodulation Lab., Policlinico Le Scotte, Italy
Jean-Pascal Lefaucheur, MD, PhD, Hopital Henri Mondor, Department of Physiology, EA 4391, Paris-Est University, France
Peter B. Rosenquist, MD. Department of Psychiatry and Health Behavior
Medical College of Georgia/Georgia Regents University
W. Vaughn McCall, MD, MS, Department of Psychiatry and Health Behavior
Medical College of Georgia/Georgia Regents University
Daniel F. Maixner MD, Department of Psychiatry, University of Michigan
Shawn M. McClintock, PhD, Psychiatry and Behavioral Sciences, Duke University School of Medicine
Guy Potter, PhD, Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine
Natasha Radhu, Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada
Daniel M. Blumberger, MD, Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada
Anosha Zanjani, Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada
Zafiris J. Daskalakis, MD, PhD, Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada
Paul Fitzgerald, MD, PhD, Monash Alfred Psychiatry Research Centre, Melbourne
Colleen Loo, MD, School of Psychiatry, University of New South Wales, Sydney
Scott Aaronson, MD, Sheppard and Enoch Pratt Hospital, Maryland
Sarah H. Lisanby, MD Department of Psychiatry & Behavioral Sciences, Duke University School of Medicine